Data compiled by Redley Lamar · ChainSifter Intelligence
6Suppliers
8Customers
0Debt Items
20Related Chains
Source-Backed Evidence Depth
Radiopharm Theranostics Limited (RADX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
15Total relationships
1Distinct source URLs
4High confidence
0.733Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Radiopharm Theranostics Limited Suppliers
Ticker
Name
Confidence
Evidence
NUCLEAR-MEDICINE-SUPPLIERS
NUCLEAR-MEDICINE-SUPPLIERS
92%
We have partnered with nuclear medicine suppliers to obtain access to high-quality isotopes that can be used efficiently in our clinical trials.
MD-ANDERSON
MD-ANDERSON
85%
We have entered into license agreements with prestigious universities and institutions that have allowed us to exclusively use, globally, novel technology to develop our clinical assets.
Reciprocal relationship from LNTH graph: ble for the performance of certain key tasks or functions, for example related to manufacturing or regulatory strategy, or where decisions may be controlled b…
Reciprocal relationship from RDPTF graph: their eligibility to be recouped, to develop a pattern of expected percentage completion at each stage of the project. In doing so, management make judgments…
Reciprocal relationship from TLPPF graph: Reciprocal relationship from RADX graph: Reciprocal relationship from TLPPF graph: her strengthens our supply chain, reducing environmental impact while maxi…
Reciprocal relationship from TLX graph: Reciprocal relationship from RADX graph: Reciprocal relationship from TLX graph: Reciprocal relationship from RADX graph: Reciprocal relationship from TLX grap…
Radiopharm Theranostics Limited Customers
Ticker
Name
Confidence
Evidence
RADIOPHARM-VENTURES-LLC
RADIOPHARM-VENTURES-LLC
90%
We have a pipeline of six licensed platform technologies and a joint venture with MD Anderson in Houston, one of the world’s leading cancer research centers, called “Radiopharm Ventures LLC” which ha…
Reciprocal relationship from LNTH graph: Reciprocal relationship from RADX graph: Reciprocal relationship from LNTH graph: tion and the potential that efforts to extend or secure separate or otherwis…
Reciprocal relationship from TLPPF graph: y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to se…
Reciprocal relationship from ASX graph: Reciprocal relationship from RADX graph: Reciprocal relationship from ASX graph: Reciprocal relationship from RADX graph: Reciprocal relationship from ASX grap…
DELAWARE-PHARMA15-CORPORATION
DELAWARE-PHARMA15-CORPORATION
62%
s of our drug candidates and related treatments will be available in the United States and worldwide from government health administration authorities, private health insurers and other organizations…
NEVADA-RADIOPHARM-VENTURES-LLC
NEVADA-RADIOPHARM-VENTURES-LLC
62%
s of our drug candidates and related treatments will be available in the United States and worldwide from government health administration authorities, private health insurers and other organizations…
THERANOSTICS-LIMITED
THERANOSTICS-LIMITED
62%
iopharm Theranostics Limited Notes to the financial statements 30 June 2025 1 Segment information Management has determined, based on the reports reviewed by the chief operating decision maker that a…
UNITED-STATES-FOREIGN-UNITED-STATES-RADIOPHARM-V
UNITED-STATES-FOREIGN-UNITED-STATES-RADIOPHARM-V
62%
tial ordinary shares. (n) Revenue recognition The group recognizes revenue as follows: Revenue from contracts with customers Revenue is recognized at an amount that reflects the consideration to whic…
Radiopharm Theranostics Limited Debt Obligations
No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Radiopharm Theranostics Limited.
Radiopharm Theranostics Limited Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Radiopharm Theranostics Limited.
Radiopharm Theranostics Limited Ownership
Holder
Name
Confidence
Evidence
RADX-OWNER-STONEPINE-CAPITAL-MANAGEMENT-LLC
Stonepine Capital Management, LLC
90%
13F overlay lists Stonepine Capital Management, LLC as top holder; 8 tracked holders.
